Last updated: 18 July 2019 at 8:22pm EST

Gregory M. Bortz Net Worth




The estimated Net Worth of Gregory M. Bortz is at least 104 千$ dollars as of 14 January 2019. Gregory Bortz owns over 9,184 units of Enzo Biochem stock worth over 104,006$ and over the last 15 years Gregory sold ENZ stock worth over 0$.

Gregory Bortz ENZ stock SEC Form 4 insiders trading

Gregory has made over 2 trades of the Enzo Biochem stock since 2017, according to the Form 4 filled with the SEC. Most recently Gregory exercised 9,184 units of ENZ stock worth 24,797$ on 14 January 2019.

The largest trade Gregory's ever made was exercising 59,455 units of Enzo Biochem stock on 31 October 2017 worth over 171,230$. On average, Gregory trades about 5,720 units every 37 days since 2010. As of 14 January 2019 Gregory still owns at least 93,699 units of Enzo Biochem stock.

You can see the complete history of Gregory Bortz stock trades at the bottom of the page.



What's Gregory Bortz's mailing address?

Gregory's mailing address filed with the SEC is C/O ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK, NY, 10022.

Insiders trading at Enzo Biochem

Over the last 22 years, insiders at Enzo Biochem have traded over 2,615,763$ worth of Enzo Biochem stock and bought 1,070,494 units worth 3,103,461$ . The most active insiders traders include Bradley Louis RadoffManagement Corp Harbert Dis...Elazar Rabbani. On average, Enzo Biochem executives and independent directors trade stock every 127 days with the average trade being worth of 59,099$. The most recent stock trade was executed by Kara Cannon on 21 February 2024, trading 10,640 units of ENZ stock currently worth 11,810$.



What does Enzo Biochem do?

enzo biochem inc is a financial services company located in 60 executive blvd, farmingdale, new york, united states.



Complete history of Gregory Bortz stock trades at Enzo Biochem

インサイダー
取引
取引
合計金額
Gregory M. Bortz
ディレクター
オプション行使 24,797$
14 Jan 2019
Gregory M. Bortz
ディレクター
オプション行使 171,230$
31 Oct 2017


Enzo Biochem executives and stock owners

Enzo Biochem executives and other stock owners filed with the SEC include: